Redx About us Our pipeline Our science Investors News & events Contact us Key Leadership Team Lisa Anson Chief Executive Officer Experienced General Manager, former President of AstraZeneca UK and has significant leadership experience in pharmaceuticals Dr. Richard Armer Chief Scientific Officer Experienced drug discovery executive, ex Pfizer, Organon, Ardana, Oxagen, Lectus Therapeutics Andrew Booth Group Financial Controller Experienced Financial Controller and Company Secretary of listed companies Dr. Peter Bunyard Head of Inflammation & Fibrosis Expert in immunology, inflammation and fibrosis and obtained a phD in immunology from University College London Peter Collum Chief Financial Officer Experienced biopharma finance and strategy executive, previously CFO and CBO of Pharnext SA Dr. Karl Hård Head of Investor Relations Experienced biopharma investor relations and communications executive, previously with AstraZeneca, Kiadis and Optimum Strategic Communications Dr. Cliff Jones Head of Chemistry Experienced medicinal chemist with broad drug discovery expertise, previously with AstraZeneca in the UK and France Dr. James Mead Chief Operating Officer Previously CFO of AstraZeneca Netherlands, with wide sector experience Dr. Caroline Phillips Head of Oncology Extensive experience in drug discovery and early clinical development Dr. Jane Robertson Chief Medical Officer Experienced oncology drug developer ex. AstraZeneca, Achilles, Nucana. Led the successful clinical development of Lynparza Craig Tilston Head of Development Operations Experienced drug developer ex. AstraZeneca and Pfizer. Closely involved with the development of a number of successful compounds including Tagrisso™, Lipitor™, Champix™ and Viagra™ Redx Copyright © 2021 Redx Pharma Plc Privacy & terms Cookie policy Website design & build by Carr Kamasa Design We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies. Cookie Policy. I Accept

Redx About us Our pipeline Our science Investors News & events Contact us Board of Directors Dr Jane Griffiths Designate Chair (from 1st December 2021) Former Global Head of Actelion Peter Presland Interim Chairman Finance, Audit and Corporate Governance specialist with several high profile organisations Lisa Anson Chief Executive Officer Experienced General Manager, former President of AstraZeneca UK Dr Bernhard Kirschbaum Non-Executive Director Former Executive Vice-President of Global Research at Merck Serono Sarah Gordon Wild Non-Executive Director Highly experienced industry analyst Dr Tom Burt Non-Executive Director Investor Director representing Sofinnova Crossover 1 SLP Natalie Berner Non-Executive Director Investor Director representing Redmile Redx Copyright © 2021 Redx Pharma Plc Privacy & terms Cookie policy Website design & build by Carr Kamasa Design We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies. Cookie Policy. I Accept